Minerva Neurosciences Statistics
Total Valuation
NERV has a market cap or net worth of $15.45 million. The enterprise value is $48.30 million.
Important Dates
The last earnings date was Tuesday, November 5, 2024, before market open.
| Earnings Date | Nov 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
NERV has 6.99 million shares outstanding. The number of shares has increased by 27.34% in one year.
| Current Share Class | 6.99M |
| Shares Outstanding | 6.99M |
| Shares Change (YoY) | +27.34% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 4.02% |
| Owned by Institutions (%) | 44.05% |
| Float | 5.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 0.76 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.23
| Current Ratio | 6.23 |
| Quick Ratio | 5.92 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.63 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -28.91% |
| Return on Capital (ROIC) | -31.21% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$367,950 |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -59.39% in the last 52 weeks. The beta is 0.17, so NERV's price volatility has been lower than the market average.
| Beta (5Y) | 0.17 |
| 52-Week Price Change | -59.39% |
| 50-Day Moving Average | 2.55 |
| 200-Day Moving Average | 3.13 |
| Relative Strength Index (RSI) | 31.99 |
| Average Volume (20 Days) | 25,443 |
Short Selling Information
The latest short interest is 7,080, so 0.10% of the outstanding shares have been sold short.
| Short Interest | 7,080 |
| Short Previous Month | 7,205 |
| Short % of Shares Out | 0.10% |
| Short % of Float | 0.13% |
| Short Ratio (days to cover) | 0.50 |
Income Statement
| Revenue | n/a |
| Gross Profit | -12.40M |
| Operating Income | -24.50M |
| Pretax Income | -33.65M |
| Net Income | -3.31M |
| EBITDA | -24.49M |
| EBIT | -24.50M |
| Earnings Per Share (EPS) | -$0.44 |
Full Income StatementBalance Sheet
The company has $26.53 million in cash and $60.00 million in debt, giving a net cash position of -$33.47 million or -$4.79 per share.
| Cash & Cash Equivalents | 26.53M |
| Total Debt | 60.00M |
| Net Cash | -33.47M |
| Net Cash Per Share | -$4.79 |
| Equity (Book Value) | -21.67M |
| Book Value Per Share | -3.10 |
| Working Capital | 23.45M |
Full Balance SheetCash Flow
| Operating Cash Flow | -20.38M |
| Capital Expenditures | n/a |
| Free Cash Flow | -20.38M |
| FCF Per Share | -$2.91 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NERV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -27.34% |
| Shareholder Yield | -27.34% |
| Earnings Yield | -21.43% |
| FCF Yield | -131.84% |
Analyst Forecast
The average price target for NERV is $5.00, which is 126.26% higher than the current price. The consensus rating is "Hold".
| Price Target | $5.00 |
| Price Target Difference | 126.26% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on June 21, 2022. It was a reverse split with a ratio of 0.125:1.
| Last Split Date | Jun 21, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.125:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |